Genomic surveillance of clinical Pseudomonas aeruginosa isolates reveals an additive effect of carbapenemase production on carbapenem resistance

Authors

Luke Diorio-Toth, Washington University School of Medicine in St. Louis
Sidra Irum, National University of Sciences and Technology, Islamabad, Pakistan
Robert F Potter, Washington University School of Medicine in St. Louis
Meghan A Wallace, Washington University School of Medicine in St. Louis
Muhammad Arslan, Pakistan Institute of Medical Sciences
Tehmina Munir, National University of Medical Sciences, Rawalpindi, Pakistan
Saadia Andleeb, National University of Sciences and Technology, Islamabad, Pakistan
Carey-Ann D Burnham, Washington University School of Medicine in St. Louis
Gautam Dantas, Washington University School of Medicine in St. Louis

Journal

Microbiology Spectrum

Publication Date

6-29-2022

Volume

10

Issue

3

First Page

e0076622

Document Type

Open Access Publication

DOI

10.1128/spectrum.00766-22

Rights and Permissions

Diorio-Toth L, Irum S, Potter RF, Wallace MA, Arslan M, Munir T, Andleeb S, Burnham CD, Dantas G. Genomic Surveillance of Clinical Pseudomonas aeruginosa Isolates Reveals an Additive Effect of Carbapenemase Production on Carbapenem Resistance. Microbiol Spectr. 2022 Jun 29;10(3):e0076622. doi: 10.1128/spectrum.00766-22. Copyright © 2022 Diorio-Toth et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

Recommended Citation

Diorio-Toth, Luke; Irum, Sidra; Potter, Robert F; Wallace, Meghan A; Arslan, Muhammad; Munir, Tehmina; Andleeb, Saadia; Burnham, Carey-Ann D; and Dantas, Gautam, "Genomic surveillance of clinical Pseudomonas aeruginosa isolates reveals an additive effect of carbapenemase production on carbapenem resistance." Microbiology Spectrum. 10, 3. e0076622 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/12060